![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/18 | |
A61K 31/195 | |||
A61K 31/635 | |||
A61P 29/00 |
(11) | Number of the document | 2207541 |
(13) | Kind of document | T |
(96) | European patent application number | 08836080.5 |
Date of filing the European patent application | 2008-09-20 | |
(97) | Date of publication of the European application | 2010-07-21 |
(45) | Date of publication and mention of the grant of the patent | 2014-10-29 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2008/007953 |
Date | 2008-09-20 |
(87) | Number | WO 2009/043495 |
Date | 2009-04-09 |
(30) | Number | Date | Country code |
07019521 | 2007-10-05 | EP | |
15256 | 2007-12-20 | US | |
08013725 | 2008-07-31 | EP |
(72) |
RUDOLPHI, Karl, DE
MICHAELIS, Martin, DE
GUEHRING, Hans, DE
|
(73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
(54) | USE OF SULFONYL-SUBSTITUTED 2-SULFONYLAMINOBENZOIC ACID N-PHENYLAMIDES IN THE TREATMENT OF PAIN |
USE OF SULFONYL-SUBSTITUTED 2-SULFONYLAMINOBENZOIC ACID N-PHENYLAMIDES IN THE TREATMENT OF PAIN |